SPOTLIGHT: Merck scraps AIDS vaccine

Over the weekend Merck announced that it was scrapping development of a promising AIDS vaccine after researchers concluded that it had failed a large international study. This was considered a major setback in the effort to develop an AIDS vaccine. In the trial, 24 volunteers receiving the vaccine contracted AIDS compared to 21 in the control group. Release [1]